Arrowhead Pharmaceuticals, Inc 10-K for FY2025
Arrowhead Pharmaceuticals, Inc. (ARWR)
10-K
2025-11-25
For: 2025-09-30
View Original
Added on
April 08, 2026
About this 10-K
Arrowhead Pharmaceuticals, Inc filed this 10-K on November 25, 2025, covering the fiscal year ended September 30, 2025 (FY2025).
Headline figures
Fiscal year ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $829.45M
- up 23258.2% from $3.55M a year earlier
- Net loss
- $1.63M
- compared with a net loss of $599.49M a year earlier
- Diluted EPS
- -$0.01
- compared with -$5.00 a year earlier